• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination

tetano

Editor, Senior Moderator
Ann Fam Med. 2017 Nov;15(6):507-514. doi: 10.1370/afm.2120.
[h=1]Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination.[/h] Regan AK[SUP]1,[/SUP][SUP]2[/SUP], Bloomfield L[SUP]3,[/SUP][SUP]4[/SUP], Peters I[SUP]5[/SUP], Effler PV[SUP]3,[/SUP][SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]PURPOSE:[/h] Seasonal influenza vaccine is recommended and funded for groups at higher risk of serious infection, but uptake is suboptimal. We conducted a randomized controlled trial of short message service (SMS) reminders for influenza vaccination.
[h=4]METHODS:[/h] Six weeks after seasonal influenza vaccinations began, we identified high-risk patients who had a mobile telephone number on record at 10 practices in Western Australia. Thirty-two percent of the selected patients had already been vaccinated in the current year and were ineligible. Of the remaining 12,354 eligible patients at each practice one-half were randomly assigned to receive a vaccination reminder by SMS (intervention) and the rest received no SMS (control). Approximately 3 months after the SMS was sent (the study period), vaccination data were extracted from the patients' electronic medical records. Log-binomial regression models were used to calculate the relative risk (RR) of vaccination between the intervention and control group.
[h=4]RESULTS:[/h] Twelve-percent (769 of 6,177) of the intervention group and 9% (548 of 6,177) of the control group were vaccinated during the study period, a 39% relative increase attributable to the SMS (RR = 1.39; 95% CI, 1.26-1.54). For every 29 SMSs sent, costing $3.48, 1 additional high-risk patient was immunized. The greatest effect was observed for children younger than 5 years, whose parents were more than twice as likely to have their child vaccinated if they received a SMS reminder (RR = 2.43; 95% CI, 1.79-3.29).
[h=4]CONCLUSION:[/h] We found SMS reminders to be a modestly effective, low-cost means to increase seasonal influenza vaccine coverage among high-risk patients.
? 2017 Annals of Family Medicine, Inc.


[h=4]KEYWORDS:[/h] health promotion; health services; influenza vaccines; text messaging

PMID: 29133488 DOI: 10.1370/afm.2120
Free full text
 
Back
Top Bottom